Nucleoside analog studies indicate mechanistic differences between RNA-editing adenosine deaminases

Nucleic Acids Research

Volumn 40, Issue 19, 2012, Pages 9825-9835

  Mizrahi, Rena A ^a   Phelps, Kelly J ^a   Ching, Andrea Y ^a   Beal, Peter A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DEAMINASE ACTING ON RNA 1; ADENOSINE DEAMINASE ACTING ON RNA 2; AMINO ACID; NUCLEOSIDE DERIVATIVE; RNA EDITING ADENOSINE DEAMINASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEAMINATION; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME SUBSTRATE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA ANALYSIS; RNA EDITING; RNA SYNTHESIS; SACCHAROMYCES CEREVISIAE;

ADENOSINE; ADENOSINE DEAMINASE; AMINO ACID SEQUENCE; DNA GLYCOSYLASES; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; RNA EDITING; RNA PRECURSORS; RNA, MESSENGER; RNA-BINDING PROTEINS; SEQUENCE ALIGNMENT; TRANSCRIPTION, GENETIC; TUBERCIDIN;

EID: 84868088487     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks752     Document Type: Article

References (82)

1. Wang, J., Zhang, J., Li, K., Zhao, W. and Cui, Q. (2012) SpliceDisease database: linking RNA splicing and disease. Nucleic Acids Res., 40, D1055-D1059.
2. Suzuki, T., Nagao, A. and Suzuki, T. (2011) Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs. Wiley Interdiscip. Rev. RNA, 2, 376-386.
3. Ruggero, D., Grisendi, S., Piazza, F., Rego, E., Mari, F., Rao, P.H., Cordon-Cardo, C. and Pandolfi, P.P. (2003) Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science, 299, 259-262. (Pubitemid 36125213)
4. Iwamoto, K. and Kato, T. (2003) RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci. Lett., 346, 169-172. (Pubitemid 36829288)
5. Kawahara, Y., Ito, K., Sun, H., Aizawa, H., Kanazawa, I. and Kwak, S. (2004) Glutamate receptors: RNA editing and death of motor neurons. Nature, 427, 801.
6. Kwak, S. and Kawahara, Y. (2005) Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis. J. Mol. Med., 83, 110-120. (Pubitemid 40379299)
7. Niswender, C.M., Herrick-Davis, K., Dilley, G.E., Meltzer, H.Y., Overholser, J.C., Stockmeier, C.A., Emeson, R.B. and Sanders-Bush, E. (2001) RNA editing of the human serotonin 5-HT2C receptor: Alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharm., 24, 478-491. (Pubitemid 32244309)
8. Sodhi, M.S., Burnet, P.W.J., Makoff, A.J., Kerwin, R.W. and Harrison, P.J. (2001) RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Mol. Psychiatry., 6, 373-379. (Pubitemid 32566085)
9. Vissel, B., Royle, G.A., Christie, B.R., Schiffer, H.H., Ghetti, A., Tritto, T., Perez-Otano, I., Radcliffe, R.A., Seamans, J., Sejnowski, T. et al. (2001) The role of RNA editing of kainate receptors in synaptic plasticity and seizures. Neuron., 29, 217-227. (Pubitemid 32108734)
10. Kishore, S. and Stamm, S. (2006) The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science, 311, 230-232. (Pubitemid 43108188)
11. Vitali, P., Basyuk, E., Le Meur, E., Bertrand, E., Muscatelli, F., Cavaillé , J. and Huttenhofer, A. (2005) ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs. J. Cell Biol., 169, 745-753. (Pubitemid 41002880)
12. Morabito, M.V., Abbas, A.I., Hood, J.L., Kesterson, R.A., Jacobs, M.M., Kump, D.S., Hachey, D.L., Roth, B.L. and Emeson, R.B. (2010) Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol. Dis., 39, 169-180.
13. Doe, C.M., Relkovic, D., Garfield, A.S., Dalley, J.W., Theobald, D.E.H., Humby, T., Wilkinson, L.S. and Isles, A.R. (2009) Loss of the imprinted snoRNA mbii-52 leads to increased 5htr2c pre-RNA editing and altered 5HT2CR-mediated behaviour. Hum. Mol. Genet., 18, 2140-2148.
14. Silberberg, G., Lundin, D., Navon, R. and Ohman, M. (2012) Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders. Hum. Mol. Genet., 21, 311-321.
15. Miyamura, Y., Suzuki, T., Kono, M., Inagaki, K., Ito, S., Suzuki, N. and Tomita, Y. (2003) Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. Am. J. Hum. Genet., 73, 693-699. (Pubitemid 37076285)
16. Cenci, C., Barzotti, R., Galeano, F., Corbelli, S., Rota, R., Massimi, L., Di Rocco, C., O'Connell, M.A. and Gallo, A. (2008) Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J. Biol. Chem., 283, 7251-7260.
17. Galeano, F., Leroy, A., Rossetti, C., Gromova, I., Gautier, P., Keegan, L.P., Massimi, L., Di Rocco, C., O'Connell, M.A. and Gallo, A. (2010) Human BLCAP transcript: new editing events in normal and cancerous tissues. Int. J. Cancer, 127, 127-137.
18. Ma, C.H., Chong, J.H., Guo, Y., Zeng, H.M., Liu, S.Y., Xu, L.L., Wei, J., Lin, Y.M., Zhu, X.F. and Zheng, G.G. (2011) Abnormal expression of ADAR1 isoforms in Chinese pediatric acute leukemias. Biochem. Biophys. Res. Commun., 406, 245-251.
19. Paz, N., Levanon, E.Y., Amariglio, N., Heimberger, A.B., Ram, Z., Constantini, S., Barbash, Z.S., Adamsky, K., Safran, M., Hirschberg, A. et al. (2007) Altered adenosine-to-inosine RNA editing in human cancer. Genome Res., 17, 1586-1595. (Pubitemid 350074854)
20. Dominissini, D., Moshitch-Moshkovitz, S., Amariglio, N. and Rechavi, G. (2011) Adenosine-to-inosine RNA editing meets cancer. Carcinogenesis, 32, 1569-1577.
21. Gurevich, I., Tamir, H., Arango, V., Dwork, A.J., Mann, J.J. and Schmauss, C. (2002) Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron., 34, 349-356. (Pubitemid 34465494)
22. Melcher, T., Maas, S., Herb, A., Sprengel, R., Seeburg, P.H. and Higuchi, M. (1996) A mammalian RNA editing enzyme. Nature, 379, 460-464. (Pubitemid 26039528)
23. Doyle, M. and Jantsch, M.F. (2003) New and old roles of the doublestranded RNA-binding domain. J. Struct. Biol., 140, 147-153.
24. Lehmann, K.A. and Bass, B.L. (2000) Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry, 39, 12875-12884.
25. Patterson, J.B. and Samuel, C.E. (1995) Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell. Biol., 15, 5376-5388.
26. Poulsen, H., Nilsson, J., Damgaard, C.K., Egebjerg, J. and Kjems, J. (2001) CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain. Mol. Cell. Biol., 21, 7862-7871. (Pubitemid 32988794)
27. Desterro, J.M.P., Keegan, L.P., Lafarga, M., Berciano, M.T., O'Connell, M. and Carmo-Fonseca, M. (2003) Dynamic association of RNA-editing enzymes with the nucleolus. J. Cell Sci., 116, 1805-1818. (Pubitemid 36582167)
28. Sansam, C.L., Wells, K.S. and Emeson, R.B. (2003) Modulation of RNA editing by functional nucleolar sequestration of ADAR2. Proc. Natl Acad. Sci. USA, 100, 14018-14023. (Pubitemid 37499183)
29. Eckmann, C.R., Neunteufl, A., Pfaffstetter, L. and Jantsch, M.F. (2001) The human but not the Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein. Mol. Biol. Cell, 12, 1911-1924. (Pubitemid 33049688)
30. Strehblow, A., Hallegger, M. and Jantsch, M.F. (2002) Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain. Mol. Biol. Cell., 13, 3822-3835. (Pubitemid 35398551)
31. George, C.X. and Samuel, C.E. (1999) Characterization of the 5'-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter. Gene, 229, 203-213. (Pubitemid 29148324)
32. George, C.X. and Samuel, C.E. (1999) Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc. Natl Acad. Sci. USA, 96, 4621-4626. (Pubitemid 29190386)
33. Kawakubo, K. and Samuel, C.E. (2000) Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter. Gene, 258, 165-172.
34. Marcucci, R., Brindle, J., Paro, S., Casadio, A., Hempel, S., Morrice, N., Bisso, A., Keegan, L.P., Del Sal, G. and O'Connell, M.A. (2011) Pin1 and WWP2 regulate GluR2 Q/R site RNA editing by ADAR2 with opposing effects. EMBO J., 30, 4211-4222.
35. Desterro, J.M.P., Keegan, L.P., Jaffray, E., Hay, R.T., O'Connell, M.A. and Carmo-Fonseca, M. (2005) SUMO-1 modification alters ADAR1 editing activity. Mol. Biol. Cell, 16, 5115-5126. (Pubitemid 41566825)
36. Hartner, J.C., Schmittwolf, C., Kispert, A., Müller, A.M., Higuchi, M. and Seeburg, P.H. (2004) Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J. Biol. Chem., 279, 4894-4902. (Pubitemid 38199085)
37. Hartner, J.C., Walkley, C.R., Lu, J. and Orkin, S.H. (2009) ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat. Immunol., 10, 109-115.
38. Wang, Q., Miyakoda, M., Yang, W., Khillan, J., Stachura, D.L., Weiss, M.J. and Nishikura, K. (2004) Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J. Biol. Chem., 279, 4952-4961. (Pubitemid 38199091)
39. XuFeng, R., Boyer, M.J., Shen, H., Li, Y., Yu, H., Gao, Y., Yang, Q., Wang, Q. and Cheng, T. (2009) ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc. Natl Acad. Sci. USA, 106, 17763-17768.
40. Higuchi, M., Maas, S., Single, F.N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R. and Seeburg, P.H. (2000) Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature, 406, 78-81. (Pubitemid 30460214)
41. Li, M., Yang, L., Li, C., Jin, C., Lai, M., Zhang, G., Hu, Y., Ji, J. and Yao, Z. (2010) Mutational spectrum of the ADAR1 gene in dyschromatosis symmetrica hereditaria. Arch. Dermatol. Res., 302, 469-476.
42. Samuel, C.E. (2012) ADARs: viruses and innate immunity. Curr. Top. Microbiol. Immunol., 353, 163-195.
43. Macbeth, M.R., Schubert, H.L., Vandemark, A.P., Lingam, A.T., Hill, C.P. and Bass, B.L. (2005) Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science, 309, 1534-1539. (Pubitemid 41266474)
44. Yi-Brunozzi, H.Y., Easterwood, L.M., Kamilar, G.M. and Beal, P.A. (1999) Synthetic substrate analogs for the RNA-editing adenosine deaminase ADAR-2. Nucleic Acids Res., 27, 2912-2917. (Pubitemid 29335712)
45. Easterwood, L.M., Véliz, E.A. and Beal, P.A. (2000) Demethylation of 6-O-methylinosine by an RNA-editing adenosine deaminase. J. Am. Chem. Soc., 122, 11537-11538.
46. Stephens, O.M., Yi-Brunozzi, H.Y. and Beal, P.A. (2000) Analysis of the RNA-editing reaction of ADAR2 with structural and fluorescent analogues of the GluR-B R/G editing site. Biochemistry, 39, 12243-12251.
47. Yi-Brunozzi, H.Y., Stephens, O.M. and Beal, P.A. (2001) Conformational changes that occur during an RNA-editing adenosine deamination reaction. J. Biol. Chem., 276, 37827-37833.
48. Vé liz, E.A., Easterwood, L.M. and Beal, P.A. (2003) Substrate analogues for an RNA-editing adenosine deaminase: mechanistic investigation and inhibitor design. J. Am. Chem. Soc., 125, 10867-10876. (Pubitemid 37087544)
49. Haudenschild, B.L., Maydanovych, O., Vé liz, E.A., Macbeth, M.R., Bass, B.L. and Beal, P.A. (2004) A transition state analogue for an RNA-editing reaction. J. Am. Chem. Soc., 126, 11 213-11219. (Pubitemid 39223192)
50. Maydanovych, O. and Beal, P.A. (2006) C6-substituted analogues of 8-azanebularine: probes of an RNA-editing enzyme active site. Org. Lett., 8, 3753-3756. (Pubitemid 44378355)
51. Jayalath, P., Pokharel, S., Vé liz, E. and Beal, P.A. (2009) Synthesis and evaluation of an RNA editing substrate bearing 2'-deoxy-2'-mercaptoadenosine. Nucleos. Nucleot. Nucl., 28, 78-88.
52. Pokharel, S., Jayalath, P., Maydanovych, O., Goodman, R.A., Wang, S.C., Tantillo, D.J. and Beal, P.A. (2009) Matching active site and substrate structures for an RNA editing reaction. J. Am. Chem. Soc., 131, 11882-11891.
53. Kim, U., Wang, Y., Sanford, T., Zeng, Y. and Nishikura, K. (1994) Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc. Natl Acad. Sci. USA, 91, 11457-11461. (Pubitemid 24356363)
54. Yeo, J., Goodman, R.A., Schirle, N.T., David, S.S. and Beal, P.A. (2010) RNA editing changes the lesion specificity for the DNA repair enzyme NEIL1. Proc. Natl Acad. Sci. USA, 107, 20715-20719.
55. Abramoff, M.D., Magalhães, P.J. and Ram, S.J. (2004) Image processing with ImageJ. Biophot. Int., 11, 36-42.
56. Kelley, L.A. and Sternberg, M.J.E. (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat. Protocols, 4, 363-371.
57. Ley, H.L. III (2001) Editing of Hepatitis Delta Virus Antigenomic RNA by Recombinant Human Adenosine Deaminases That Act on RNA, PhD Dissertation, University of Utah, Salt Lake City, UT.
58. Macbeth, M.R., Lingam, A.T. and Bass, B.L. (2004) Evidence for auto-inhibition by the N terminus of hADAR2 and activation by dsRNA binding. RNA, 10, 1563-1571. (Pubitemid 39288191)
59. Eggington, J.M., Greene, T. and Bass, B.L. (2011) Predicting sites of ADAR editing in double-stranded RNA. Nat. Commun., 2, 319.
60. Schirle, N.T., Goodman, R.A., Krishnamurthy, M. and Beal, P.A. (2010) Selective inhibition of ADAR2-catalyzed editing of the serotonin 2c receptor pre-mRNA by a helix-threading peptide. Org. Biomol. Chem., 8, 4898-4904.
61. Roberson, L.M. and Rosenthal, J.J.C. (2006) An accurate fluorescent assay for quantifying the extent of RNA editing. RNA, 12, 1907-1912. (Pubitemid 44484263)
62. Maydanovych, O., Easterwood, L.M., Cui, T., Véliz, E.A., Pokharel, S. and Beal, P.A. (2007) Probing adenosine-to-inosine editing reactions using RNA-containing nucleoside analogs. Methods Enzymol., 424, 369-386.
63. Fedor, M.J. and Uhlenbeck, O.C. (1992) Kinetics of intermolecular cleavage by hammerhead ribozymes. Biochemistry, 31, 12042-12054. (Pubitemid 23011347)
64. Moore, M.J. and Sharp, P.A. (1992) Site-specific modification of pre-mRNA: the 2'-hydroxyl groups at the splice sites. Science, 256, 992-997.
65. Erion, M.D. and Reddy, M.R. (1998) Calculation of relative hydration free energy differences for heteroaromatic compounds: use in the design of adenosine deaminase and cytidine deaminase inhibitors. J. Am. Chem. Soc., 120, 3295-3304. (Pubitemid 28289065)
66. Albert, A. (1976) Covalent Hydration in Nitrogen Heterocycles. Adv. Heterocycl. Chem., 20, 117-143.
67. Wieczorek, A., Dinter-Gottlieb, G. and Gottlieb, P.A. (1994) Evidence that total substitution of adenine with 7-deazaadenine in the HDV antigenomic ribozyme changes the kinetics of RNA folding. Bioorg. Med. Chem. Lett., 4, 987-994. (Pubitemid 24121105)
68. Cavaillé , J., Buiting, K., Kiefmann, M., Lalande, M., Brannan, C.I., Horsthemke, B., Bachellerie, J.P., Brosius, J. and Hüttenhofer, A. (2000) Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proc. Natl Acad. Sci. USA, 97, 14 311-14316. (Pubitemid 32016572)
69. Wilson, D.K., Rudolph, F.B. and Quiocho, F.A. (1991) Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. Science, 252, 1278-1284. (Pubitemid 21917036)
70. Frederiksen, S. (1966) Specificity of adenosine deaminase toward adenosine and 2'-deoxyadenosine analogues. Arch. Biochem. Biophys., 113, 383-388.
71. Seela, F. and Xu, K. (2007) Pyrazolo[3, 4-d]pyrimidine ribonucleosides related to 2-aminoadenosine and isoguanosine: synthesis, deamination and tautomerism. Org. Biomol. Chem., 5, 3034-3045. (Pubitemid 47340694)
72. Bennett, L.L., Allan, P.W., Smithers, D. and Vail, M.H. (1969) Resistance to 4-aminopyrazolo (3, 4-d) pyrimidine. Biochem. Pharmacol., 18, 725-740.
73. Losey, H.C., Ruthenburg, A.J. and Verdine, G.L. (2006) Crystal structure of Staphylococcus aureus tRNA adenosine deaminase TadA in complex with RNA. Nat. Struct. Mol. Biol., 13, 153-159. (Pubitemid 43214719)
74. Sideraki, V., Mohamedali, K.A., Wilson, D.K., Chang, Z., Kellems, R.E., Quiocho, F.A. and Rudolph, F.B. (1996) Probing the functional role of two conserved active site aspartates in mouse adenosine deaminase. Biochemistry, 35, 7862-7872. (Pubitemid 26202525)
75. Zielke, C.L. and Suelter, C.H. (1971) Substrate specificity and aspects of deamination catalyzed by rabbit muscle 50-adenylic acid aminohydrolase. J. Biol. Chem., 246, 1313-1317.
76. Han, B.W., Bingman, C.A., Mahnke, D.K., Bannen, R.M., Bednarek, S.Y., Sabina, R.L. and Phillips, G.N. (2006) Membrane association, mechanism of action, and structure of Arabidopsis embryonic factor 1 (FAC1). J. Biol. Chem., 281, 14939-14947. (Pubitemid 43855198)
77. Wilson, D.K. and Quiocho, F.A. (1993) A pre-transition-state mimic of an enzyme: X-ray structure of adenosine deaminase with bound 1-deazaadenosine and zinc-activated water. Biochemistry, 32, 1689-1694. (Pubitemid 23066441)
78. Luo, M. and Schramm, V.L. (2008) Transition state structure of E. coli tRNA-specific adenosine deaminase. J. Am. Chem. Soc., 130, 2649-2655. (Pubitemid 351304780)
79. Phillips, M.A., Fletterick, R. and Rutter, W.J. (1990) Arginine 127 stabilizes the transition state in carboxypeptidase. J. Biol. Chem., 265, 20692-20698. (Pubitemid 120014063)
80. Phillips, M.A., Hedstrom, L. and Rutter, W.J. (1992) Guanidine derivatives restore activity to carboxypeptidase lacking arginine-127. Protein Sci., 1, 517-521. (Pubitemid 23016872)
81. Gildenhuys, S., Dobreva, M., Kinsley, N., Sayed, Y., Burke, J., Pelly, S., Gordon, G.P., Sayed, M., Sewell, T. and Dirr, H.W. (2010) Arginine 15 stabilizes an S(N)Ar reaction transition state and the binding of anionic ligands at the active site of human glutathione transferase A1-1. Biophys. Chem., 146, 118-125.
82. Acs, G., Reich, E. and Mori, M. (1964) Biological and Biochemical Properties of the Analogue Antibiotic Tubercidin. Proc. Natl Acad. Sci. USA, 52, 493-501.